Cervical Cancer

Zetiq Reports Success In Clinical Trial Aimed To Identify And Diagnose Cervical Cancer
Zetiq Technologies, a subsidiary of Bio-Light Ltd., has successfully completed the first arm of its cervical cancer clinical trial, aimed at identifying and diagnosing cervical cancer in biopsies via the Zetiq proprietary differential coloring stain. The goal of the trial was to demonstrate and measure the ability of Zetiq's technology to accurately diagnose the presence of cervical cancer cells and the stage of the disease, including in early stages of malignancy, in cervical biopsies.

Early Cervical Cancer Detection Saves Lives
Wisconsin State officials are marking Cervical Cancer Awareness Month today by encouraging women to receive a "Pap" screening test because early screening can help improve cervical cancer survival. A "Pap" exam can detect cervical abnormalities at an early, treatable stage before they develop into cancer.

Fears Of Promiscuity Pose Barrier To Cervical Cancer Vaccinations
The public's concerns about costs and increased promiscuity among teenagers appear to be hindering use of a vaccine against the human papilloma virus (HPV) to prevent life-threatening diseases, according to a study by researchers at Yale School of Public Health.

January Is Cervical Cancer Month - Article From Jhpiego
Imagine being diagnosed with a preventable disease in a country where access to quality health care services is not available to you. Not because you live in a remote area or because people don't care, but because the training was not available for the skilled healthcare providers treating you. Now imagine being an HIV positive woman in this country. You may have another preventable disease that can also kill you and you don't even know about it - cervical cancer.

Blogs Comment On 'Midnight' Regulations, Global AIDS Coordinator, Teen Births, Other Topics
The following summarizes recent women's health-related blog entries. ~ "How Barack Obama Can Take a Fast Track To Undoing Last-Minute Bush Regulations," Bonnie Erbe, Thomas Jefferson Street, U.S.

INVIRION Diagnostics Launches Successful Hybrid Instrument At EUROGIN 2008
INVIRION Diagnostics, LLC, successfully launched their new Molecular Hybrid Platform (MoHP) at EUROGIN 2008 (European Research Organization on Genital Infection and Neoplasia). EUROGIN is the leading international multidisciplinary organization involved in research, training, screening, prevention and information concerning genital infections, pre-cancers and cancers in women.

Advaxis' Phase II Clinical Trial "HOLD" Lifted
Advaxis Inc (OTCBB: ADXS), a biotechnology company, received permission from the U. S. Food and Drug Administration (FDA) to test its lead drug candidate, Lovaxin C, in patients with grade 2/3 cervical intraepithelial neoplasia (CIN). With this approval of the Investigational New Drug (IND) application for Lovaxin C, the FDA "HOLD" on Advaxis' clinical program has been lifted.

Cervical Cancer Screening May Be Improved By HPV Testing Followed By Cytology And Repeat HPV Testing
The use of human papillomavirus (HPV) DNA testing as an initial screening step followed by triage with a standard Pap test (cytology) and repeat HPV DNA testing may increase the accuracy of cervical cancer screening, according to a study in the Jan. 13 online issue of the Journal of the National Cancer Institute. Compared to cytology alone, the screening strategy improved detection of precancerous growths without a substantial increase in the number of false-positive tests.

January Is Cervical Health Awareness Month
According to the American Cancer Society, 3,870 mothers, daughters, and wives will die from cervical cancer in 2008. Over 11,000 new cases of cervical cancer will be diagnosed by year's end. The Cancer Institute of New Jersey (CINJ) is making experts available to discuss risk factors, treatment and prevention options surrounding cervical cancer. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Swedish Officials Investigate Ties Between AstraZeneca, Nobel Foundation Over Award For Discovery Of HPV
Swedish officials are investigating whether the pharmaceutical company AstraZeneca could have improperly influenced this year's Nobel Prize for medicine, which was awarded to the researcher who discovered the human papillomavirus, London's

Early Cervical Cancer Detection Saves Lives
Wisconsin State officials are marking Cervical Cancer Awareness Month today by encouraging women to receive a "Pap" screening test because early screening can help improve cervical cancer survival. A "Pap" exam can detect cervical abnormalities at an early, treatable stage before they develop into cancer.